Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
0.4891
Dollar change
+0.0025
Percentage change
0.51
%
Index- P/E- EPS (ttm)-0.80 Insider Own11.22% Shs Outstand85.54M Perf Week-3.91%
Market Cap42.05M Forward P/E- EPS next Y-0.49 Insider Trans19.89% Shs Float75.94M Perf Month10.66%
Income-37.28M PEG- EPS next Q-0.13 Inst Own13.84% Short Float3.01% Perf Quarter-44.29%
Sales0.03M P/S1401.83 EPS this Y4.88% Inst Trans-7.08% Short Ratio1.47 Perf Half Y-36.59%
Book/sh-0.04 P/B- EPS next Y22.72% ROA-154.24% Short Interest2.29M Perf Year-62.09%
Cash/sh0.03 P/C18.28 EPS next 5Y- ROE-914.66% 52W Range0.37 - 2.57 Perf YTD-76.49%
Dividend Est.- P/FCF- EPS past 5Y18.26% ROI-1184.92% 52W High-80.97% Beta1.67
Dividend TTM- Quick Ratio0.24 Sales past 5Y100.00% Gross Margin-5377.64% 52W Low32.19% ATR (14)0.05
Dividend Ex-Date- Current Ratio0.43 EPS Y/Y TTM-15.29% Oper. Margin-98956.56% RSI (14)44.57 Volatility7.93% 9.40%
Employees57 Debt/Eq- Sales Y/Y TTM-99.99% Profit Margin-118712.53% Recom1.00 Target Price7.67
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-27.51% Payout- Rel Volume0.42 Prev Close0.49
Sales Surprise-97.53% EPS Surprise-40.00% Sales Q/Q- EarningsNov 12 AMC Avg Volume1.56M Price0.49
SMA20-5.56% SMA50-3.58% SMA200-47.33% Trades Volume657,835 Change0.51%
Date Action Analyst Rating Change Price Target Change
Mar-01-21Initiated Northland Capital Outperform $10
Feb-03-20Downgrade Oppenheimer Outperform → Perform
Nov-07-24 07:00AM
Oct-23-24 07:00AM
Oct-16-24 07:00AM
Oct-14-24 09:55AM
Oct-09-24 06:13PM
07:00AM Loading…
Oct-01-24 07:00AM
Sep-27-24 08:30AM
Sep-26-24 07:00AM
Sep-09-24 06:53AM
03:00AM
Sep-05-24 07:00AM
Sep-03-24 07:00AM
Aug-23-24 11:42AM
Aug-21-24 09:29AM
Aug-20-24 05:09PM
12:00PM Loading…
Aug-15-24 12:00PM
Aug-13-24 07:00AM
Aug-12-24 05:30PM
04:05PM
Aug-08-24 07:00AM
Aug-07-24 05:11PM
08:00AM
Jul-30-24 08:00AM
Jul-23-24 07:00AM
Jul-01-24 06:50AM
Jun-28-24 08:00AM
May-23-24 06:00AM
May-20-24 12:00PM
May-16-24 03:07AM
May-15-24 08:55PM
04:01PM Loading…
04:01PM
May-14-24 07:00AM
May-10-24 06:31AM
Apr-25-24 07:00AM
Apr-09-24 09:29AM
Apr-08-24 07:00AM
Apr-03-24 07:00AM
Mar-27-24 11:28AM
09:57AM
Mar-19-24 08:50AM
06:41AM
Mar-18-24 08:53PM
05:20PM
04:05PM
Mar-13-24 07:00AM
Mar-11-24 07:00AM
Mar-05-24 12:59PM
08:00AM
Mar-04-24 06:21PM
06:06PM
Feb-13-24 07:00AM
Jan-26-24 09:22AM
Jan-16-24 07:00AM
Dec-15-23 08:17AM
Nov-14-23 10:38AM
Nov-13-23 04:05PM
Nov-06-23 08:00AM
Nov-02-23 07:00AM
Oct-30-23 03:52PM
07:00AM
Oct-09-23 07:00AM
Sep-21-23 08:00AM
Sep-07-23 08:00AM
Aug-24-23 06:47PM
Aug-16-23 06:00AM
Aug-14-23 09:05AM
Aug-11-23 06:08AM
Aug-10-23 04:05PM
Aug-09-23 08:00AM
Aug-07-23 08:00AM
Aug-03-23 08:00AM
Jun-26-23 08:00AM
Jun-06-23 09:00AM
Jun-01-23 08:00AM
May-12-23 06:04AM
May-11-23 04:05PM
May-08-23 04:39PM
08:17AM
08:02AM
08:00AM
02:32AM
May-04-23 08:00AM
Apr-24-23 08:00AM
Apr-05-23 07:46PM
Mar-30-23 04:05PM
Mar-23-23 08:00AM
Feb-28-23 04:05PM
Feb-22-23 06:08AM
Feb-15-23 09:51AM
Jan-12-23 12:47PM
08:00AM
Dec-20-22 08:00AM
Dec-13-22 08:00AM
Dec-08-22 08:00AM
Nov-29-22 08:00AM
Nov-23-22 04:05PM
Nov-13-22 07:04AM
Nov-10-22 04:05PM
Nov-03-22 08:00AM
Oct-21-22 08:00AM
Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company offers a piezo-print technology to deliver micro-doses of micro-therapeutics for the eyes. Its products include MicroProst, MicroStat, MicroTears, and MicroPine. The firm is currently focused on the late-stage development of microdosed medications for presbyopia, myopia progression, and mydriasis. The company was founded by Sean Ianchulev on March 12, 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rowe Michael MChief Executive OfficerAug 28 '24Buy0.5227,07114,077109,998Aug 28 08:01 PM
Rowe Michael MChief Executive OfficerAug 26 '24Buy0.5750,00028,50082,927Aug 27 01:06 PM
Grant Stuart M.10% OwnerJul 02 '24Buy0.661,515,1511,000,00010,914,153Jul 03 03:18 PM
Grant Stuart M.10% OwnerMar 28 '24Buy0.98100,00098,0005,430,715Mar 28 03:50 PM
Grant Stuart M.10% OwnerMar 19 '24Buy1.2350,00061,5005,330,715Mar 20 05:44 PM
Grant Stuart M.10% OwnerMar 08 '24Buy1.5810,71716,9115,280,715Mar 11 08:11 AM
Rowe Michael MChief Executive OfficerDec 04 '23Buy1.364,8906,65032,927Dec 05 04:54 PM